ob0003ou9 | Keynote: COVID, obesity & diabetes update | OU2021
Whyte Martin
The last 18-months has witnessed the collision of the epidemics of diabetes, obesity and COVID-19. The consistent finding of adverse outcomes, from COVID-19, in individuals with diabetes and/or obesity even with hyperglycaemia in the non-diabetic range has focused attention on the metabolic dysfunction that may arise with acute illness and the potential benefit to be gained from glycaemic regulation. Significantly worse outcomes in people with microvascular compl...